ALEXANDRIA, Virginia, May 18 -- The Journal of Clinical Oncology, a journal from the American Society of Clinical Oncology that says it disseminates clinical oncology research, published research articles on the following topics in its May 20, 2023 edition:

ORIGINAL REPORTS:

* Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial